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Abstract
Given the importance of Jak2 in cell signaling, a critical role for Jak2 in immune cells especially dendritic cells (DCs) has long
been proposed. The exact function for Jak2 in DCs, however, remained poorly understood as Jak2 deficiency leads to
embryonic lethality. Here we established Jak2 deficiency in adult Cre
+/+Jak2
fl/fl mice by tamoxifen induction. Loss of Jak2
significantly impaired DC development as manifested by reduced BMDC yield, smaller spleen size and reduced percentage
of DCs in total splenocytes. Jak2 was also crucial for the capacity of DCs to mediate innate immune response. Jak2
2/2 DCs
were less potent in response to inflammatory stimuli and showed reduced capacity to secrete proinflammatory cytokines
such as TNFa and IL-12. As a result, Jak2
2/2 mice were defective for the early clearance of Listeria after infection. However,
their potency to mediate adaptive immune response was not affected. Unlike DCs, Jak2
2/2 macrophages showed similar
capacity secretion of proinflammatory cytokines, suggesting that Jak2 selectively modulates innate immune response in a
DC-dependent manner. Consistent with these results, Jak2
2/2 mice were remarkably resistant to lethal dose of LPS-induced
septic shock, a deadly sepsis characterized by the excessive innate immune response, and adoptive transfer of normal DCs
restored their susceptibility to LPS-induced septic shock. Mechanistic studies revealed that Jak2/SATA5 signaling is pivotal
for DC development and maturation, while the capacity for DCs secretion of proinflammatory cytokines is regulated by both
Jak2/STAT5 and Jak2/STAT6 signaling.
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Introduction
Dendritic cells (DCs) are the most potent antigen presenting
cells (APCs) known today [1]. Other than their well-recognized
role in mediating adaptive immune response, they also serve as a
key component of innate immunity and bridge innate and
adaptive immune response to bacteria and other pathogens [2–
4]. The pathogen associated molecular patterns (PAMPs) or
damage associated molecular patterns (DAMPs) are first sensed by
pathogen recognition receptors (PRRs) expressed on their surface,
followed by initiating a serial prompt responses such as endocytosis
and cytokine secretion. Immune disorders are a system out of
balance as manifested by either excessive or defective response,
and septic shock is a typical example caused by the excessive
innate immune response [5–10]. Septic shock (or endotoxic shock)
is a severe sepsis with organ hypoperfusion and hypotension that
are poorly responsive to initial fluid resuscitation. The mortality
rate in patients with septic shock ranges from 20 to 80%, and in
the USA alone it is estimated that more than 100,000 deaths occur
each year [11,12]. Therefore, septic shock has been accounted for
the most common cause of death in the intensive care unit
[13–15]. Given the importance of DCs in the vanguard of innate
immune response, research into the development of new septic
therapeutics has focused more and more on their crucial role in
orchestrating the initial host response to infection [16], but the
advancement has been painfully slow and fraught with difficulties.
The ideal therapeutic target for septic shock would be directed to
selectively modulate innate immune response without affecting
adaptive defense. Nevertheless, it would be a formidable challenge
to characterize such a target among all immune regulatory
molecules within the genome.
Jak2 is one of the four janus kinase members identified in
mammals [17,18]. It acts as a critical component of signal
pathways involved in cellular survival, proliferation, differentiation
and apoptosis [19–21]. Particularly, Jak2 has been suggested to be
crucial for the regulation of DC development and functionality
[22–25]. However, the exact function for Jak2 in DCs remained,
somehow, controversial depending on each particular chemical
inhibitor used. In the present study, we induced Jak2 deficiency in
adult mice by crossing Jak2
fl/fl mice with Cre-ERT2 transgenic
mice. Loss of Jak2 only selectively suppresses the capacity of DCs
to initiate innate immune response, but there is no discernable
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a result, Jak2
2/2 mice are remarkably resistant to lethal dose of
LPS-induced septic shock. Our results suggest that Jak2 could be a
unique therapeutic target for the intervention and treatment of
clinical septic shock.
Results
Jak2 Is Essential for DC Development and Maturation
Cre
+/+Jak2
fl/fl mice were generated by crossing Cre-ERT2
transgenic mice with Jak2
fl/fl mice as described. For induction of
Jak2 deficiency, 8 wk-old male Cre
+/+Jak2
fl/fl mice were i.p.
injected with tamoxifen (25 mg/kg body weight) for five
consecutive days. Male littermates administered with carrier
solution (10% ethanol in corn oil) were used as controls. To
confirm Jak2 deficiency, the mice were sacrificed after 2 wk of last
injection. Bone marrow derived dendritic cells (BMDCs) and
splenocytes were prepared and subjected to Western blot analysis
of Jak2 expression. As shown in Figure 1A, BMDCs originated
from control mice showed high levels of Jak2 expression, while
Jak2 was undetectable in BMDCs of tamoxifen induced mice.
Similar results were also observed in splenocytes (data not shown).
Collectively, these results indicate that tamoxifen efficiently
induced Jak2 deficiency in Cre
+/+Jak2
fl/fl mice.
We first sought to address the impact of Jak2 deficiency on DC
development. To this end, 1610
7 bone marrow cells originated
from Jak2
2/2 and control littermates were induced with GM-CSF
and IL-4 to generate BMDCs, respectively. Jak2 deficiency
significantly reduced DC production, a 1.3-fold decrease for
BMDC yield was observed in Jak2
2/2 mice as compared with that
of control mice (Figure 1B). We also noticed a significant smaller
size for spleens in Jak2
2/2 mice than that of control mice
(5268 mg vs. 157610 mg, p,0.001; Figure 1C). In line with this
observation, total splenocytes in Jak2
2/2 mice were significantly
less than that of controls (Figure 1D, left panel). Next, we
examined splenic DCs. To our surprise, in addition to the reduced
number of total splenocytes, the percentage of DCs in spenocytes
has also significantly decreased (Figure 1D, right panel). In
contrast, we failed to detect a significant alteration for the
percentage of CD4 and CD8 T cells in total spenocytes (data not
shown). Together, these data suggest that loss of Jak2 significantly
impaired DC development.
We next examined DC phenotypic differences between Jak2
2/2
and control mice. For this purpose, day-9 BMDC cultures were
stimulated with 0.5 mg/ml LPS overnight and harvested on day-10
for flow cytometry analysis of surface marker expressions. Both
Jak2
2/2 and control bone marrow cells produced .85% purity of
DCs, which were then gated for the analysis of surface MHC-II,
CD80, CD86, and CD54 expressions. In contrast to previous
published data [26,27], loss of Jak2 rendered DCs significant less
potent in response to maturation stimulation. We first noticed that
much lower percentage of Jak2
2/2 BMDCs expressing MHC-II
and co-stimulatory molecules such as CD80, CD86 and CD54
before stimulation (Figure 1E). Upon LPS stimulation, majority of
control BMDCs became matured as characterized by high levels
of MHC-II, CD80, CD86 and CD54 expressions. In sharp
contrast, only a small proportion of Jak2
2/2 BMDCs became
matured (Figure 1F). To further confirm this observation, we
analyzed splenic DCs. Single splenic cells were prepared and then
co-stained for CD11c and MHC-II or one of the above indicated
costimulatory molecules. Similar as BMDCs, significant lower
percentage of Jak2
2/2 splenic DCs expressed high levels of MHC-
II and costimulatory molecules (Figure S1). To further confirm
these observations, we treated BMDCs with AG490, a broadly
used Jak2 inhibitor. In contrast to previously published data [27],
but consistent with our current data observed on Jak2
2/2 mice,
AG490 significantly suppressed DC maturation (Figure S2). We
also tested the impact of tamoxifen on DC maturation and failed
to detect any perceptible effect (Figure S3).
We next examined the impact of Jak2 deficiency on macro-
phages, another important type of professional APCs. Peritoneal
exudate macrophages (PEM) were collected by peritoneal lavage
as described. Western blot analysis confirmed the absence of Jak2
in PEM derived from Jak2
2/2 mice (data not shown). The cells
were then subjected to flow cytometry analysis as above. To our
surprise, we failed to observe a significant difference for the
number of macrophages between Jak2
2/2 and control mice, and
Western analysis also confirmed Jak2 deficiency in PEM derived
from Jak2
2/2 mice (data not shown). However, similar as DCs,
Jak2
2/2 macrophages showed a less matured phenotype charac-
terized by the lower percentage of cells expressing MHC-II and
costimulatory molecules as compared with that of control mice
(Figure S4).
Jak2 Deficiency Attenuates the Capacity of DCs to Initiate
Innate Immune Response
Next, we examined the capacity of Jak2
2/2 DCs secretion of
proinflammatory cytokines such as TNFa and IL-12 using the
above culture supernatants. Before stimulation IL-12 was
undetectable in both wild-type and Jak2
2/2 cultures, while low
levels of TNFa were detected, but the amount in Jak2
2/2 cultures
was 12-fold lower than that of control cultures (Figure 2A). Upon
LPS stimulation BMDCs secreted copious amounts of TNFa and
IL-12, and consistently, Jak2
2/2 BMDCs secreted much lower
levels of TNFa and IL-12 as compared with that of control
BMDCs (Figure 2A). However, both wild-type and Jak2
2/2
BMDCs showed similar capacity for secretion of IL-10 (Figure
S5A).Similarly, we analyzed cytokine secretion from Jak2
2/2
macrophages. Supernatants harvested from above PEM cultures
were examined for TNFa and IL-12 production by ELISA assay.
Very surprisingly, unlike Jak2
2/2 DCs, macrophages deficient for
Jak2 showed similar capacity to secrete TNFa and IL-12 as that of
wild-type cells (Figure 2B). All together, these data suggest that loss
of Jak2 only selectively impairs the capacity of DCs to initiate
innate immune response.
To further confirm above observations, we checked Listeria
clearance in Jak2
2/2 mice as innate immunity especially the
production of proinflammatory cytokines plays a pivotal role in the
early clearance of Listeria after infection [28–31]. For this purpose,
Mice were systemically infected by i.v. injection with 1610
6 CFU
(,1L D 50)o fListeria, and organs from Jak2
2/2 and control mice
were harvested after 2-day of infection. Dilutions of spleen and liver
homogenates were plated on TSB-agar and colonies were counted
after 2-day of culture, respectively. In line with above results,
Jak2
2/2 mice showed significant lower capacity for early clearance
of Listeria as manifested by 50–100 times more colonies observed in
Jak2
2/2 mice as compared with that of control mice (Figure 2C).
Jak2
2/2 DCs Possess Similar Capacity to Mediate
Adaptive Immune Response
The above results prompted us to check whether Jak2 deficiency
would affect the capability of DCs to mediate adaptive immune
response. We first performed allogenic MLR to examine the
capacity of DCs to stimulate T cell proliferation. To this end,
irradiated Jak2
2/2 and control BMDCs were cocultured with T
cells originated from BALB/c mice, and T cell proliferation was
determined by
3H thymidine incorporation. Unexpectedly,
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2/2 BMDCs showed similar potency as control BMDCs to
stimulate alloreactive BALB/c T cell proliferation (Figure 3A, left
panel). To confirm this observation, we performed similar studies
using splenic DCs. Splenocytes pooled from 5 Jak2
2/2 or control
mice were used to enrich splenic DCs as described. Irradiated
splenic DCs (2000 rads) were then cocultured with BALB/c T cells
as above, respectively. Consistently, splenic Jak2
2/2 DCs were
potent to stimulate alloreactive T cell activation (Figure 3A, right
panel). We next examined the capacity of Jak2
2/2 DCs to initiate
antigen-specific T cell activation. For this purpose, irradiated
Figure 1. Jak2 is essential for DC development and maturation. (A) Tamoxifen efficiently induced Jak2 deficiency in DCs. BMDCs were
generated from Cre
+/+Jak2
fl/fl mice after 2 wk of tamoxifen or carrier solution induction and then subjected to Western blot analysis of Jak2
expression. High levels of Jak2 were detected in control mice, while Jak2 was absent in tamoxifen induced mice. (B) Loss of Jak2 significantly reduced
BMDC yield. Bone marrow cells (1610
7) were used to generate BMDCs using GM-CSF (10 ng/ml) and IL-4 (5 ng/ml) as described. Bone marrow cells
deficient for Jak2 showed 1.3-fold decrease of BMDC yield. (C) Jak2
2/2 mice show significant smaller spleen size. Top panel: a bar graphic figure
showing the average spleen weight of all mice analyzed; bottom panel: representative spleens from Jak2
2/2 and control mice. (D) Analysis of
splenocytes in Jak2
2/2 and control mice. Both total splenocytes and the percentage of splenic DCs in total splenocytes were reduced in Jak2
2/2 mice
as compared with that of controls. (E) BMDC surface marker expressions in the unstimulated condition. Left panel: a representative of flow cytometry
data; right panel: a bar graphic figure showing the average percentage of BMDCs positive for each surface marker analyzed. (F) BMDC surface marker
expressions after LPS stimulation. Similar as above, left panel is a representative of flow cytometry data, and right panel shows the average
percentage of BMDCs positive for the corresponding surface marker. All data are present as mean 6 SE of four replicates. *, p,0.05; **, p,0.01;
***, p,0.001.
doi:10.1371/journal.pone.0009593.g001
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2/2 BMDCs or splenic DCs were first pulsed with 1 mM
OVA peptide, and then cocultured with OT-1 T cells as above.
Similarly, both Jak2
2/2 BMDCs and splenic DCs were potent to
stimulate antigen-specific T cell activation (Figure 3B).
Next, we analyzed cytokine profile of T cells activated by
Jak2
2/2 DCs. We selectively analyzed the production of IFN-c
(Th1), IL-10 (Th2) and IL-17 (Th17) by ELISA analysis of above
collected culture supernatants. Once again, Jak2
2/2 DCs were as
potent as control DCs to stimulate T cells secretion of IFN-c, IL-
10, and IL-17 (Figure 3C). Taken together, these results indicate
that loss of Jak2 only selectively inhibits the potency of DCs to
initiate innate immune response without perceptible effect on DC-
mediated adaptive immune response.
Jak2
2/2 Mice Are Remarkably Resistant to Lethal Dose of
LPS-Induced Septic Shock
Given the role that Jak2 selectively regulates DC-mediated innate
immune response, we next examined its implication in the
pathogenesis of septic shock, in which excessive innate immune
response is suggested to be responsib l ef o rt h ed i s e a s ee t i o l o g y[ 3 2 –
34]. To this end, 8 wk-old male Cre
+/+Jak2
fl/fl mice were first induced
with tamoxifen or control vehicle as above. Four weeks later, lethal
dose of LPS (50 mg/kg body weight) was then administered into each
mouse via i.p. injection. In general, all control mice were much
weaker as compared with that of Jak2
2/2 mice after 6–12 h of
injection, and remarkably, 14 out of 18 control mice (78%) died
within 36 h of injection. In sharp contrast, 17 out of 20 Jak2
2/2 mice
have completely recovered from lethal dose of LPS challenge
(Figure 4A, 85% vs. 22%, p,0.0001), indicating that loss of Jak2
protected mice from lethal dose of LPS-induced septic death.
To confirm that the protective effect observed in Jak2
2/2 mice was
DC-dependent, we next performed an adoptive transfer study using
DCs originated from wild-type mice. To this end, the irradiated
Jak2
2/2 mice and their corresponding controls were adoptively
transferred 1610
7 normal BMDCs followed by challenging with lethal
dose of LPS as described. As expected, both Jak2
2/2 and control mice
Figure 2. Jak2 deficiency selectively attenuates the capacity of DCs to initiate innate immune response. (A) Loss of Jak2 attenuates the
capacity of DCs secretion of proinflammatory cytokines. Supernatants of BMDCs with or without LPS stimulation were harvested and subjected to
ELISA analysis of cytokine secretion. BMDCs deficient for Jak2 showed significant reduced capacity to secrete TNFa and IL-12. (B) Jak2 failed to show
perceptible impact on macrophages secretion of proinflammatory cytokines. PEM derived from Jak2
2/2 and control mice were cultured with or
without LPS stimulation and supernatants were harvested for ELISA analysis as above, respectively. (C) Jak2
2/2 mice showed impaired early clearance
of Listeria. Jak2
2/2 and control mice were i.v. injected with ,1 LD50 Listeria Monocytogenes in PBS. Spleens and livers were harvested after 48 h
infection. Serial 10-fold dilutions of organ homogenates were plated on TSB-agar and CFU were counted after 48 h incubation. Left panel: a
representative results for cultures inoculated with homogenates; right panel: a bar graphic figure showing the average CFU/organ of 3 independent
experiments. All data are present as mean 6 SE. *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0009593.g002
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(Figure 4B), demonstrating that DCs with reduced capacity to initiate
innate immune response protected Jak2
2/2 mice from septic shock.
To further address above question, we examined serum TNFa
and IL-12 production in mice challenged with nonlethal dose of
LPS (150 mg/mouse). Serum samples were collected from both
Jak2
2/2 and control mice after 12 h of LPS challenge. Sera
pooled from 3 mice of each study group were subjected to ELISA
analysis of cytokine production. Consistent with above observa-
tions, Jak2
2/2 mice produced significant lower levels of serum
TNFa and IL-12 as compared with that of control mice
(Figure 4C). Interestingly, we observed much higher levels of
serum IL-2 in Jak2
2/2 mice although IL-2 levels for both Jak2
2/2
and control mice were relatively low (Figure 4C). Similar as in
vitro studies, we failed to detect significant differences for serum
IL-10 between Jak2
2/2 and control mice after LPS challenge
(Figure S5B). As DC apoptosis is a potential causative factor for
post-septic death, we examined DC apoptosis by flow cytometry.
BMDCs were treated with 10 mg/ml LPS for 96 h and then
stained with Annexin-V and PI for flow cytometry analysis. We
failedtodetecta significantdifferenceofapoptosisbetweenJak2
2/2
and control BMDCs (Figure S6A). We further analyzed splenic DC
apoptosis in Jak2
2/2 mice after 20 h of LPS challenge (150 mg/
mouse), and similar results were obtained (Figure S6B).
Loss of Jak2 Impairs the Activation of STAT3, 4, 5, and 6
To investigate the underlying mechanisms by which Jak2
regulates DC-mediated innate immune response, 2610
6/ml
Jak2
2/2 or control BMDCs were stimulated with 1 mg/ml LPS
for 30 min and then harvested for Western blot analysis of target
molecules. Given the importance of NFkB signaling in LPS-induced
immune response, we first examined phosphorylated IkBa (pIkBa)
in BMDC lysates. To our surprise, we failed to detect a significant
difference for pIkBa between Jak2
2/2 and control BMDCs
(Figure 5A). Therefore, Jak2 regulation of DCs for secretion of
proinflammatory cytokines seems to be independent of NFkB
signaling. We next examined the activation states of downstream
signalingmolecules.AsSTATsignalinghasbeendemonstratedtobe
crucial for cytokine receptors to transduce intracellular signals, we
therefore checked the phosphorylation states of transcription factors
STAT1, STAT3, STAT4, STAT5 and STAT6. It was found that
loss of Jak2 significantly attenuated STAT3, 4, 5 and 6 activation in
BMDCs as manifested by the significant decreased levels for
phosphorylated STAT3 (pSTAT3, Figure 5B), pSTAT4
(Figure 5C), pSTAT5 (Figure 5D) and pSTAT6 (Figure 5E). In
contrast, Jak2 did not show a perceptible effect on STAT1 activation
(Figure 5F). To demonstrate why macrophages deficient for Jak2
showed similar capacity secretion of proinflammatory cytokines, we
furtherexaminedtheactivationstatesofallSTATfactorsinJak2
2/2
macrophages as above. Unlike DCs, loss of Jak2 in macrophages
only affected the activation of STAT3 and 4 (Figure S7).
Jak2/STAT5 Signaling Is Indispensable for DC
Development and Maturation
We next sought to examine the functional relevance of Jak2/
STAT5 signaling in DCs. Stat5-Tg mice and their control
Figure 3. DCs deficient for Jak2 show similar potency to stimulate T cell activation. (A) Allogenic MLR results. (B) Antigen-specific MLR
results. (C) ELISA analysis of cytokines produced by the activated T cells. MLR were carried out using either BALB/c T cells (allogenic) or OT-1 T cells
(antigen-specific) as responders in the condition of DC/T ratio 1:10. T cell proliferation was estimated by
3H thymidine incorporation. Data shown in
the figure are mean 6 SE of three independent experiments performed.
doi:10.1371/journal.pone.0009593.g003
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2/2 mice,
the weight of spleens and number of splenocytes were significantly
higher in Stat5-Tg mice as compared with their control littermates
(Figure 6A). Consistent with this observation, the yield of BMDCs
from Stat5-Tg mice was 1.6-fold higher than that of their control
littermates (Figure 6B, left panel). Similarly, the percentage of
splenic DCs in total splenocytes was significantly higher than their
control littermates (Figure 6B, right panel). We further examined
the impact of Jak2/STAT5 signaling on DC maturation. Similar
as above, DCs were generated from bone marrow cells originated
from Stat5-Tg mice and control littermates, respectively, and then
stimulated with LPS overnight. As shown in Figure 6C, significant
higher percentage of BMDCs derived from Stat5-Tg mice
expressing high levels of MHC-II and costimulatory molecules
such as CD80, CD86 and CD54 before and after LPS stimulation,
as compared with their control littermates. We next examined
cytokine secretion using the above culture supernatants. Interest-
ingly, BMDCs with transgenic Stat5 expression showed similar
capacity to secret TNFa, however, much higher levels of IL-12
was noted (Figure 6D). Together, our results suggest that Jak2/
STAT5 signaling plays an indispensable role in DC development,
maturation and IL-12 secretion.
Jak2/STAT6 Is Essential for DCs Secretion of
Proinflammatory Cytokines
To delineate whether Jak2/STAT4 and Jak2/STAT6 signaling
implicate in DC development and DC-mediated innate immune
response, Stat4
2/2 and Stat6
2/2 mice were used for the study. It is
noteworthy that we failed to detect significant alterations for DC
development and maturation in both Stat4
2/2 and Stat6
2/2 mice
(data not shown). As a result, our next focus is to examine their
implications in the regulation of cytokine secretion. Before
stimulation, BMDCs only secreted low levels of TNFa, while IL-
12 was undetectable in the cultures of all BMDCs (Figure 6E).
However, high levels of TNFa and IL-12 were detected after LPS
stimulation and Stat6
2/2 BMDCs showed significant lower
capacity to secret TNFa and IL-12, although we observed
relatively higher levels of TNFa in Stat6
2/2 BMDCs in the
unstimulated condition (Figure 6E). All of these results demon-
strate that Jak2/STAT6 signaling regulates the capacity of DCs to
secrete cytokines implicated in innate immune response. To our
surprise, we failed to detect a significant impact for Jak2/STAT4
signaling on either DC development or cytokine secretion.
Previous studies demonstrated that STAT4 levels directly correlate
with IL-12-dependent IFNc production by DCs during antigen
Figure 4. Jak2
2/2 mice show DC-dependent resistance to lethal dose of LPS-induced septic shock. (A) The survival rates of Jak2
2/2 and
control mice were monitored for 4 days after lethal dose of LPS challenge. It was noticed that mice would completely recover from septic shock if
they did not die within 36 h of lethal dose of LPS challenge. 85% of Jak2
2/2 mice (17 out of 20) have completely recovered from septic shock, while
only 22% of control mice (4 out of 18) have survived (p,0.0001). (B) Adoptive transfer of normal DCs into irradiated Jak2
2/2 mice restored their
susceptibility to LPS-induced septic shock. Irradiated Jak2
2/2 or control mice were first adoptively transferred with 1610
7 normal BMDCs followed by
lethal dose of LPS challenge. Jak22/2 mice after adoptive transfer of normal DCs showed similar survival rate as that of control mice, indicating that
the resistant phenotype for septic shock seen in Jak2
2/2 mice is DC-dependent. (C) ELISA analysis of serum cytokines of nonlethal dose of LPS
challenged mice. Both Jak2
2/2 and control mice were first challenged with nonlethal dose of LPS (150 mg/mouse) and 12 h later the mice were
sacrificed, respectively. Sera were pooled from three mice and then subjected to ELISA analysis of cytokine production. Three pools were analyzed for
each study group. Jak2
2/2 mice produced significant lower levels of proinflammatory cytokines as compared with that of control mice. The data are
present as mean 6 SE of three replicates. *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0009593.g004
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implicates in DC-mediated T cell polarization. Consistent with
this assumption, we failed to detect DCs originated from both
Jak2
2/2 and control mice secretion of IFNc after LPS stimulation
despite lower percentage of DCs carrying high levels of MHC-II
and costimulatory molecules in Jak2
2/2 mice (data not shown).
As mice deficient for Stat3 lead to embryonic lethality [36], we
used DC2.4 cells, a B6-derived DC line, for the study. DC2.4 cells
were transfected with a Stat3 siRNA or a scramble RNA as
described. Western blot analysis confirmed a significant reduction
for the active form of STAT3 in response to LPS stimulation in
cells transfected with siRNA (Figure 6F, left panel). Culture
supernatants were then collected and subjected to analysis of
proinflammatory cytokine secretion. To our surprise, we failed to
detect IL-12 production in all cultures either before or after LPS
stimulation. However, DC2.4 cells secreted high levels of TNFa,
but no significant difference was noted between cells transfected
with siRNA and scramble RNA (Figure 6F, right panel), indicating
that Jak2/STAT3 signaling may not affect the capacity of DCs
secretion of proinflammatory cytokines. Several recent studies
suggested a role for Stat3 in DC development and differentiation
[37–39], and therefore, Jak2/STAT3 is possibly to work together
with Jak2/STAT5 signaling involved in DC development.
Discussion
Given the importance of Jak2 in both physiological and
pathological conditions, a critical role for Jak2 in immune cells
especially DCs has long been proposed. However, despite past
extensive studies, its exact function in DCs remains controversial
[26,27,35,40]. The main reason for the discrepant results is that
most studies were conducted using Jak2 inhibitors as loss of Jak2 is
embryonic lethal, while those inhibitors could non-specifically
target other molecules. In this study, we have generated an
inducible Jak2 deficient model by crossing Jak2
fl/fl mice with Cre-
ERT2 transgenic mice. We first performed studies to examine the
implication of Jak2 in DC development. We have demonstrated
that loss of Jak2 impairs DC development as manifested by the
reduced BMDC yield, smaller spleen size, and reduced percentage
of DCs in total splenocytes (Figures 1B–D). Other than this
recognized role, we further noticed a pivotal role for Jak2 in the
regulation of the capacity for DCs to mediate innate immune
response. Jak2
2/2 DCs were found to be less potent in response to
inflammatory stimuli (Figures 1E & 1F), and furthermore, they
showed significant reduced capacity to secrete proinflammatory
cytokines such as TNFa and IL-12 upon LPS stimulation
(Figure 2A). As a result, Jak2
2/2 mice were defective for the
early clearance of Listeria after infection as compared with that of
control mice (Figure 2C). However, their potency to mediate
adaptive immune response such as the capacity to activate
allogenic or antigen specific T cells was not affected (Figures 3A–
C). Very interestingly, it appears that Jak2 regulation of innate
immune response is DC-dependent as macrophages deficient for
Jak2 showed similar capacity secretion of proinflammatory
cytokines such as TNFa and IL-12 (Figure 2B). This discrepancy
could be caused by the difference for the STAT activation profile
between DCs and macrophages. For example, Jak2 deficiency
affected the activation of STAT3, 4, 5 and 6 in DCs (Figure 5),
while defective activation was only noted for STAT3 and 4 in
Jak2
2/2 macrophages (Figure S7). Together, our data suggest that
Jak2 selectively modulates innate immune response which appears
to be DC-dependent.
To further dissect the role of Jak2 in DC-mediated innate
immune response, we used septic shock, a typical disorder
characterized by the uncontrolled innate immune response, as a
model for the study. Septic shock is a severe sepsis due to excessive
release of proinflammatory cytokines such as TNFa and IL-12,
which then lead to vasodilation, increased vascular permeability,
hypotension, multiple organ failure and ultimately shock and
death. Unlike septic death resulted from late phase of sepsis, septic
shock is manifested by excessive innate immune response such as
copious amount of proinflammatory cytokine release. Therefore,
Jak2 signaling might be a potential therapeutic target for
controlling excessive innate immune response during septic shock.
Cecal ligation and puncture (CLP) is a widely used experimental
model for sepsis [41]. However, animals die after CLP usually
Figure 5. Western blot analysis of the activation states of Jak2 downstream molecules. 2610
6/ml Jak2
2/2 and control BMDCs were
harvested after 30 min of LPS stimulation (1 mg LPS/ml) and cell lysates were prepared for Western blot analysis of the phosphorylated form of
signaling molecules. (A) pIkBa; (B) phosphorylated STAT3 (pSTAT3); (C) pSTAT4; (D) pSTAT5; (E) pSTAT6; and (F) pSTAT1. Four independent
experiments were performed and consistent results were obtained.
doi:10.1371/journal.pone.0009593.g005
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immune response and maladaptive immune response. Since our
focus is to determine Jak2 deficiency in DC-mediated innate
immune response, it would be crucial to ultimately exclude the
implication of adaptive immune response. As a result, we have
chosen lethal dose of LPS-induced septic shock for the study. As
expected, 78% of control mice died from septic shock within 36 h
of lethal dose of LPS challenge, while 85% of Jak2
2/2 mice have
survived from the same dose of LPS challenge (Figure 4A),
indicating that Jak2
2/2 mice were protected from LPS-induced
septic shock. Adoptive transfer studies were then applied to further
address that this protective effect is DC-dependent. Since
macrophages deficient for Jak2 only showed defective activation
for STAT3 and 4 (Figure S7), we selected adoptive transfer of DCs
for the study, in which 1610
7 normal DCs were transferred into
irradiated Jak2
2/2 mice. As expected, Jak2
2/2 mice after
Figure 6. Jak2/STAT5 signaling is indispensable for DC development and maturation, while the capacity of DC for secretion of
proinflammatory cytokines is regulated by both Jak2/STAT5 and Jak2/STAT6 signaling. (A) Stat5-Tg mice show larger size for the spleen
and higher number of splenocytes. (B) Transgenic Stat5 expression enhances BMDC yield and increases the percentage of splenic DCs in total
splenocytes (C) DCs with transgenic Stat5 expression show higher potency in response to LPS stimulation. Significant higher percentage of DCs show
matured phenotype as characterized by high levels of MHC II and costimulatory molecule expressions before/after LPS stimulation. (D) ELISA analysis
of cytokines secreted by DCs with transgenic Stat5 expression. Stat5-Tg BMDCs showed similar capacity for secretion of TNFa, while the production of
IL-12 was significantly higher than that of control BMDCs after LPS stimulation. (E) ELISA analysis of cytokine secretion by BMDCs generated from
Stat4
2/2 and Stat6
2/2 mice. Stat6
2/2 BMDCs showed significant lower capacity for secretion of TNFa and IL-12 upon LPS stimulation. In contrast,
Stat4
2/2 BMDCs showed similar capacity for secretion of above indicated cytokines as control BMDCs. (F) Down-regulation of Stat3 in DC2.4 cell by
siRNA. DC2.4 cells were first transfected with a Stat3-specific siRNA or a scramble RNA followed by LPS stimulation for analysis of cytokine secretion.
Left panel: Western blot results showing significant down-regulation of pSTAT3 in cells transfected with siRNA. Right panel: ELISA analysis of cytokine
secretion. IL-12 was undetectable in both siRNA and scramble transfected DC2.4 cells, while siRNA transfected DC2.4 cells showed similar capacity for
secretion of TNFa. Data shown in the figure are presented as mean 6 SE. *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0009593.g006
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LPS-induced septic shock (Figure 4B). These results demonstrate
that DCs with reduced capacity for initiation of innate immune
response rendered Jak2
2/2 mice more resistant to LPS-induced
septic shock. In consistent with this conclusion, ELISA analysis of
serum cytokines revealed significant lower levels of proinflamma-
tory cytokines such as TNFa and IL-12 in Jak2
2/2 mice after 12 h
of nonlethal dose of LPS challenge (Figure 4C), while the
production of IL-10 was similar between Jak2
2/2 and control
mice (Figure S5).
Of note, unlike TNFa and IL-12, we noticed much higher levels
of serum IL-2 in Jak2
2/2 mice after LPS challenge as compared
with control mice, although the absolute IL-2 level was relatively
low in both strains of mice (Figure 4C). Recent studies
demonstrated that microbial stimuli (not proinflammatory cyto-
kines) are able to induce IL-2 secretion by DCs [42–44], while we
failed to detect IL-2 secretion in DCs following LPS stimulation
which could be due to the differences of our culture system or
lower sensitivity of our detection system. Given the important
regulatory role exerted by IL-2 in the immune system, it has been
suggested to be tightly regulated by the STAT5-dependent
negative feedback signal [45]. Therefore, the reduced Stat5 activity
probably contributes to the observed higher levels of serum IL-2 in
Jak2
2/2 mice. Studies have shown that DC-derived IL-2 plays a
pivotal role in their capability to prime alloreactive T cells [42,46],
and therefore, enhanced IL-2 production in Jak2
2/2 DCs
probably contributes to their unchanged potency to stimulate
allogenic or antigen specific T cell activation as well.
Given the important role of Jak2 in cell signaling, we anticipate
that Jak2 deficiency would affect the activation of multiple
signaling pathways of DCs. Unexpectedly, we only detected
altered activity for Stat3, 4, 5 and 6 (Figure 5). It seems that loss of
Jak2 in DCs has negligible impact on Stat1 and NFkB signaling,
which could be due to the compensated effect from other
redundant Jak kinases. For example, other than Jak2, Stat1 can
be activated by either Jak1 or Tyk2 [47]. Using Stat5-Tg mice, we
have demonstrated evidence indicating that Jak2/STAT5 is
indispensable for DC development and maturation in response
to inflammatory stimulation. In opposite to Jak2
2/2 mice, Stat5-
Tg mice displayed higher DC yield, larger spleen size and higher
potency in response to LPS stimulation (Figure 6). However, Jak2/
STAT5 only partly regulates DCs secretion of IL-12, indicating
additional signaling pathway(s) that are also implicated in the
regulation of DCs secretion of proinflammatory cytokines.
To examine the possible implication of additional signaling
pathway(s), we performed studies in Stat6
2/2 mice and demon-
strated a pivotal role for Jak2/STAT6 signaling in the regulation
of cytokine secretion in DCs. We noticed a significant impaired
production of TNFa and IL-12 in Stat6
2/2 DCs following LPS
stimulation, although Stat6
2/2 DCs secreted relatively higher
baseline of TNFa (Figure 6E). Based on the results for TNFa and
IL-12 production, there is no doubt that Jak2/STAT6 signaling
regulates the capacity of DCs secretion of proinflammatory
cytokines. We further performed similar studies in Stat4
2/2 mice
and DC2.4 cells transfected with a Stat3 siRNA. Surprisingly, we
failed to detect any perceptible impact for STAT3 and STAT4 on
the capacity of DCs for cytokine secretion (Figures 6E & F). Given
the importance of STAT4 pathway in T cell polarization [48–51],
Jak2/STAT4 signaling could be implicated in the regulation of
DCs to mediate T cell polarization. On the other hand, STAT3
has been recently suggested to be important for DC development
and differentiation [37–39], and therefore, Jak2/STAT3 could
work together with Jak2/STAT5 signaling to implicate in DC
development.
Extensive studies have been conducted for decades to
demonstrate the function of Jak2 in immune cells including DCs
by using different Jak2 inhibitors. Results derived from these
studies, however, remained controversial, because of non-specific-
ity of each Jak2 inhibitor. To our knowledge, the present report is
the first study carried out in adult mice deficient for Jak2. Due to
the complexity of Jak2 in the regulation of immune responses, we
have limited our current study to APCs, particularly, to DC-
mediated innate immune response. The implication of Jak2 in the
regulation of adaptive immunity is yet to be determined. We are
also aware that Jak2 is essential for the development and
functionality of other immune cells such as T and B cells. Future
studies focused on demonstrating these questions would shed light
to the development of novel therapeutic approaches to diseases
such as cancer and autoimmune disorders [52].
In conclusion, we have demonstrated the function of Jak2 in the
regulation of DC development, maturation and cytokine secretion.
Our data strongly support that Jak2 only selectively regulates the
capacity of DCs to initiate innate immune response, while their
capacity to stimulate T cell activation is not impacted. As a result,
mice deficient for Jak2 show a DC-dependent resistance to lethal
dose of LPS-induced septic shock, a deadly disorder caused by the
excessive innate immune response. Together, our data suggest that
Jak2 could be a unique therapeutic target for the intervention and
treatment of clinical septic shock.
Materials and Methods
Mice
Stat4
2/2 (H-2
d), Stat6
2/2 (H-2
d) and BALB/cJ (H-2
d) mice were
purchased from the Jackson’s Laboratory. Cre-ERT2 transgenic
mice under the control of human ubiquitin C promoter (H-2
b),
Jak2
fl/fl mice (H-2
b), C57/BL6 (H-2
b) mice, Stat5b transgenic
(Stat5-Tg) mice (H-2
d) and OT-1 transgenic mice (H-2
b) were bred
and housed in the SPF facility of Medical College of Georgia
(MCG). All studies were carried out in compliance with MCG and
Tongji Medical College Animal Care and Use Committee
guidelines.
Induction of Jak2 Deficiency
Cre
+/+Jak2
fl/fl mice were intraperitoneally (i.p.) injected with
tamoxifen (25 mg/kg body weight) for 5 consecutive days.
Tamoxifen was freshly dissolved in corn oil supplemented with
10% ethanol before injection. Cre
+/+Jak2
fl/fl littermates injected
with equal volume of corn oil with 10% ethanol were served as
controls.
Generation of BMDCs
Bone marrow cells were flushed from femurs and tibias, and
5610
5/ml cells were plated in 150-mm Petri dishes and cultured
with RPMI-1640 supplemented with 10% FCS, GM-CSF (10 ng/
ml) and IL-4 (5 ng/ml) (PeproTech, Rocky Hill, NJ). Suspended
cells were discarded at day-4 and the cultures were replaced with
fresh media at day-7. BMDCs were then stimulated with LPS
(0.5 mg/ml, Sigma, St Louis, MO) overnight and harvested on
day-10 for experimental purpose [53].
Isolation of PEM
PEM were collected by peritoneal lavage as reported with minor
modifications [54]. Briefly, mice were i.p. injected with 5 ml
sterilized cold RPMI 1640. PEM were harvested by washing
peritoneal lavage twice with 5 ml cold RPMI 1640. After lysis of
red blood cells, the cells were incubated for 3 h at 37uCi n
35615 mm culture dishes. Non-adherent cells were removed by
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collected for experimental purpose.
Western Blot Analysis
Total proteins were prepared from BMDCs or splenocytes using
RIPA lysis buffer supplemented with protease inhibitors. Western
blot analysis was carried out as reported by probing the blots with
an indicated primary Ab (Santa Cruz, CA) followed by an HRP-
conjugated secondary antibody. The reactive bands were
visualized using an ECL Plus
TM Western blot kit (PIERCE,
Rockford, IL) [55]. b-actin was used for normalization. All
Western blotting antibodies were purchased from Santa Cruz.
Flow Cytometry Analysis
BMDCs or splenic single cell suspensions were prepared and
washed with PBS. After blocking with anti-mouse CD16/32 Fcc
III/II receptor, the cells were stained for CD11c, CD11b, I-A
d,
CD80, CD86, and CD54 as reported [56]. After washes, the cells
were suspended in FACS buffer and analyzed on a FACSCalibur
(BD Bioscience, San Jose, CA). The data were analyzed using
CellQuest v3.3 software as instructed. All flow cytometry
antibodies were purchased from BD Bioscience.
ELISA Analysis of Cytokines
The amount of TNFa, IL-2, IL-10, IL-12, IL-17 and IFN-c in
the culture media and sera was determined using the sandwich
ELISA kits (eBioscience, San Diego, CA) as reported [57].
Mixed Lymphocyte Reaction (MLR)
Splenic DCs originated from Jak2
2/2 and control mice were
purified using a mouse DC enrichment kit (StemCell, Seattle,
WA). For allogenic MLR, T cells isolated from BALB/cJ mice
were co-cultured with irradiated (2000 rad) BMDCs or splenic
DCs (2610
5/ml, DC:T=1:10) originated from Jak2
2/2 or
control mice for 56 h followed by additional 16 h in the presence
of 0.5 mCi/well
3H thymidine. For antigen-specific MLR,
2.5610
5/ml irradiated (2000 rad) Jak2
2/2 BMDCs or splenic
DCs were pulsed with 1 mM OVA peptide and then co-cultured
with 5610
5/ml splenocytes isolated from OT-1 transgenic mice as
above. After washes, the cells were finally harvested on glass wool
filters with a suction-water-wash apparatus, dried, and counted in
a beta scintillation counter [57]. T cell proliferation was estimated
as mean CPM (counts per minute) 6 SE.
Listeria monocytogenes Infection
Jak2
2/2 and control mice were i.v. injected with 1610
6 CFU
(,1L D 50) Listeria Monocytogenes (LM-ova, a modified Listeria strain
expressing OVA) in PBS as reported [58,59]. Determination of
Listeria Monocytogenes titer was carried out as previously described
with minor modifications [59]. Briefly, spleens and livers were
harvested after 48 h infection and homogenized in sterile distilled
water containing 0.2% triton X-100. After 30 min incubation at
room temperature, serial 10-fold dilutions were plated on TSB-
agar and incubated at 37uC. Colonies were counted after 48 h
incubation.
Stat3 siRNA Transfection in DC2.4 Cells
DC2.4 cells were transfected with a Stat3 siRNA or a scramble
RNA (Santa Cruz, CA) as instructed by the manufacturer. The
cells were stimulated with 0.5 mg/ml LPS after 24 h transfection.
Cell lysates and culture supernatants were then subjected to
Western blot and ELISA analysis after 24 h stimulation,
respectively.
Induction of LPS-Challenged Septic Shock
For induction of septic shock, the mice were first i.p. injected
with 50 mg/kg body weight of LPS (Sigma, St Louis, MO), and
then subjected to evaluation of mortality and behavior changes
every 6 h for .96 h. Mice injected with 150 mg LPS were used as
a model for nonlethal sepsis. Serum samples were collected using
whole blood after 12 h of injection. For adoptive transfer studies,
both Jak2
2/2 and control mice were first underwent 800 rads of
irradiation. Two days later, 1610
7 BMDCs derived from
nonirradiated control mice were injected into these irradiated
mice via tail vein, respectively. After 4 h of transfer, the mice were
underwent induction of septic shock with lethal dose of LPS
(25 mg/kg body weight) as above. Eight mice were included in
each study group.
Statistical Analysis
Survival curves for septic shock were generated by the Kaplan
and Meier method. Chi-square test was employed to determine the
difference of mortality for LPS-induced septic shock. Comparisons
between groups for flow cytometry, cytokine and MLR data were
accomplished by one-way ANOVA using SPS 11.5 for windows.
Data were present as mean 6 SE. P,0.05 was considered
statistically significant.
Supporting Information
Figure S1 Loss of Jak2 suppresses the maturation of splenic
DCs. Surface marker expressions were analyzed by flow cytometry
in splenic DCs. Each bar represents the average percentage of
DCs positive for the surface marker analyzed.
Found at: doi:10.1371/journal.pone.0009593.s001 (0.12 MB TIF)
Figure S2 AG490 suppresses BMDC maturation in a dose-
dependent manner. Bone marrow cells derived from B6 mice were
used to generate BMDCs. AG490 (0, 100 and 200 mM,
respectively) was added into the cultures on day-4. BMDCs were
stimulated with LPS (500 ng/ml) on day-9 and harvested on day-
10 for flow cytometry analysis of surface marker expressions. Left
panel: a representative flow cytometry data of three independent
experiments performed; right panel: a bar graphic figure showing
the average percentage of BMDCs positive for each surface
marker analyzed. *, p,0.05.
Found at: doi:10.1371/journal.pone.0009593.s002 (4.21 MB TIF)
Figure S3 Tamoxifen does not have perceptible effect on DC
phenotype. 25 mg/kg body weight of tamoxifen or carrier solution
were i.p. injected into B6 mice for 5 consecutive days. The mice
were sacrificed after 2 wk of last injection. Bone marrow cells were
used to generate BMDCs and surface marker expressions were
analyzed before/after LPS stimulation.
Found at: doi:10.1371/journal.pone.0009593.s003 (0.67 MB TIF)
Figure S4 Loss of Jak2 suppresses surface marker expressions in
macrophages. Macrophages deficient for Jak2 show less matured
phenotype. Each bar represents the average percentage of
macrophages positive for each surface marker analyzed.
Found at: doi:10.1371/journal.pone.0009593.s004 (0.13 MB TIF)
Figure S5 IL-10 secretion after LPS challenge (A) ELISA
analysis of IL-10 production of culture supernatants derived from
Jak22/2 and wild-type BMDCs before/after LPS (1 mg/ml)
treatment. (B) Serum IL-10 levels after LPS challenge. Both
Jak22/2 and control mice were first challenged with nonlethal
dose of LPS (150 mg/mouse) and 12 h later the mice were
sacrificed. Sera were pooled from three mice and then subjected to
ELISA analysis of IL-10.
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Figure S6 Flow cytometry analysis of apoptotic BMDCs and
splenic DCs after LPS challenge (A) BMDC apoptosis after LPS
stimulation. BMDCs were stimulated 10 mg/ml LPS for 96 h and
then stained with Annexin-V and PI followed by flow cytometry
analysis of apoptotic cells. (B) Splenic DC apoptosis after LPS
challenge. Jak22/2 and control mice were first challenged with
150 mg/mouse of LPS and were sacrificed after 20 h of injection.
Splenic DC apoptosis was then analyzed by flow cytometry as
above.
Found at: doi:10.1371/journal.pone.0009593.s006 (0.11 MB TIF)
Figure S7 Western blot analysis of the activation states of Jak2
downstream molecules in macrophages. Only STAT3 and STAT4
showed defective activation in Jak22/2 macrophages.
Found at: doi:10.1371/journal.pone.0009593.s007 (0.16 MB TIF)
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